Question 1

Does Citadel Advisors own BLTE stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 186,168 shares of BLTE (Belite Bio), worth $28.7M.

Question 2

How many shares of BLTE does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 186,168 shares of BLTE (Belite Bio).

Question 3

What is Citadel Advisors' BLTE position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' BLTE position is worth $28.7M.

Question 4

Is Citadel Advisors buying or selling BLTE?

Accepted Answer

In Q2 2026, Citadel Advisors increased its BLTE position from 2,008 to 186,168 shares.

Question 5

When did Citadel Advisors first buy BLTE?

Accepted Answer

Citadel Advisors first reported BLTE in its Q3 2024 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	186,168	+9171.3%	$28.7M	0.0%	$153.99	46
2026-Q1	Decreased	2,008	-60.3%	$320,156	0.0%	$167.88	0
2025-Q4	Decreased	5,055	-53.3%	$808,598	0.0%	$160.82	0
2025-Q3	Increased	10,827	+45.2%	$801,198	0.0%	$73.00	34
2025-Q2	Increased	7,456	+31.1%	$430,211	0.0%	$59.04	30
2025-Q1	Increased	5,689	+9.2%	$376,726	0.0%	$66.70	26
2024-Q4	Decreased	5,211	-19.3%	$328,814	0.0%	$61.97	0
2024-Q3	New	6,460	-	$302,845	0.0%	$46.55	32

BLTE8 quarters

BLTE
8 quarters